The American Academy of Pediatrics (AAP) advises breastfeeding women to avoid tanning beds due to potential risks to both mother and infant.
Maternal Risks
- Skin cancer: UV-A/B from tanning beds → DNA damage → melanoma, squamous cell carcinoma, basal cell carcinoma. Indoor tanning before age 35 increases melanoma risk 59–75%.
- Premature aging: Collagen and elastin degradation.
- Ocular damage: Cataracts, photokeratitis without protective goggles.
Potential Infant Risks (Theoretical but Biologically Plausible)
- Folate degradation in breast milk: UV radiation degrades folate (critical for infant neural development and DNA synthesis). Animal and limited human data suggest decreased milk folate with maternal UV exposure.
- Immune modulation: UV-induced systemic immunosuppression may alter milk cytokine and immunoglobulin profiles.
- Vitamin D paradox: Tanning beds emit mostly UVA (poor for vitamin D synthesis); safer to supplement mother and infant directly.
Regulatory Context
- FDA: Tanning beds Class II (moderate risk); require timers and warning labels.
- WHO/IARC: UV-emitting tanning devices = Group 1 carcinogen.
- Many US states ban minor use; no federal ban for adults.
Practical Advice
- Avoid tanning beds entirely during lactation (and pregnancy).
- If vitamin D is a concern: test 25(OH)D; supplement per guidelines (maternal 600–2000 IU/day; infant 400 IU/day).
- Sunless tanning (DHA-based) is safe for breastfeeding — no systemic absorption.
The precautionary principle favors avoidance given established maternal carcinogenicity and plausible infant risks.
